| Q98726059 | Artificial intelligence in radiation oncology |
| Q91243385 | Association between facility volume and mortality of patients with classic Hodgkin lymphoma |
| Q48142212 | Association between hospital volume and receipt of treatment and survival in patients with glioblastoma |
| Q64917315 | Centers with more therapeutic modalities are associated with improved outcomes for patients with hepatocellular carcinoma. |
| Q37141507 | Clinical impact of prolonged diagnosis to treatment interval (DTI) among patients with oropharyngeal squamous cell carcinoma. |
| Q38652852 | Clinical outcomes for patients presenting with N3 head and neck squamous cell carcinoma: Analysis of the National Cancer Database. |
| Q39791477 | Comparison of Patient- and Practitioner-Reported Toxic Effects Associated With Chemoradiotherapy for Head and Neck Cancer |
| Q38743390 | Consultation via telemedicine and access to operative care for patients with head and neck cancer in a Veterans Health Administration population |
| Q52646249 | Deep Learning Algorithm for Auto-Delineation of High-Risk Oropharyngeal Clinical Target Volumes With Built-In Dice Similarity Coefficient Parameter Optimization Function. |
| Q40086454 | Definitive intensity-modulated radiotherapy concurrent with systemic therapy for oropharyngeal squamous cell carcinoma: Outcomes from an integrated regional Australian cancer centre |
| Q59478489 | Disparities in radiation therapy delivery: current evidence and future directions in head and neck cancer |
| Q64135974 | Effect of adjuvant radiotherapy treatment center volume on overall survival |
| Q39598978 | Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234). |
| Q55339422 | Evaluation of multiple institutions' models for knowledge-based planning of volumetric modulated arc therapy (VMAT) for prostate cancer. |
| Q53048353 | Having Medicaid insurance negatively impacts outcomes in patients with head and neck malignancies. |
| Q41522410 | Head and neck cancer: improving outcomes with a multidisciplinary approach. |
| Q50531979 | Head and neck squamous cell cancers in the United States are rare and the risk now is higher among white individuals compared with black individuals. |
| Q40152615 | Human papillomavirus related oropharyngeal cancer |
| Q40759100 | IMRT experience of radiation oncologists and prognosis in head-and-neck cancer |
| Q40324587 | Impact of access to NCI- and NCCN-designated cancer centers on outcomes for multiple myeloma patients: A SEER registry analysis |
| Q36115829 | Impact of facility volume on outcomes in patients with squamous cell carcinoma of the anal canal: Analysis of the National Cancer Data Base. |
| Q93186465 | Impact of treatment expertise on the outcome of patients with head and neck cancer treated within 6 randomized trials |
| Q36914455 | Importance of Radiation Oncologist Experience Among Patients With Head-and-Neck Cancer Treated With Intensity-Modulated Radiation Therapy |
| Q52596125 | Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: Role, Controversy, and Future Directions. |
| Q39748985 | Institutional Enrollment and Survival Among NSCLC Patients Receiving Chemoradiation: NRG Oncology Radiation Therapy Oncology Group (RTOG) 0617. |
| Q40536614 | Lung cancer: Stage III NSCLC - is it time to centralize care? |
| Q36485777 | Lungtech, a phase II EORTC trial of SBRT for centrally located lung tumours - a clinical physics perspective |
| Q57461645 | Optimising Outcomes for Glioblastoma through Subspecialisation in a Regional Cancer Centre |
| Q47105326 | Outcomes of post-prostatectomy radiotherapy at a Regional Cancer Centre |
| Q58769757 | Patient choice for high-volume center radiation impacts head and neck cancer outcome |
| Q93026818 | Pattern of planned systemic therapy usage in newly diagnosed, nonmetastatic squamous cell carcinoma of the head and neck in a commercially insured population in the United States |
| Q38764833 | Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques. |
| Q91432445 | Postoperative radiation performed at the same surgical facility associated with improved overall survival in oral cavity squamous cell carcinoma |
| Q38929954 | Prospective Qualitative and Quantitative Analysis of Real-Time Peer Review Quality Assurance Rounds Incorporating Direct Physical Examination for Head and Neck Cancer Radiation Therapy |
| Q38682803 | Prospective analysis of radiation oncology image and plan-driven peer review for head and neck cancer. |
| Q91793487 | Quality of care and short and long-term outcomes of oropharyngeal cancer care in the elderly |
| Q91480149 | Radiation therapy treatment facility and overall survival in the adjuvant setting for locally advanced head and neck squamous cell carcinoma |
| Q49968491 | Radiotherapy Controversies and Prospective in Head and Neck Cancer: A Literature-Based Critical Review |
| Q90748134 | Radiotherapy Quality Assurance for Head and Neck Squamous Cell Carcinoma |
| Q52614991 | Radiotherapy quality assurance for the RTOG 0834/EORTC 26053-22054/NCIC CTG CEC.1/CATNON intergroup trial "concurrent and adjuvant temozolomide chemotherapy in newly diagnosed non-1p/19q deleted anaplastic glioma": Individual case review analysis. |
| Q46127320 | Regional variation in head and neck cancer mortality: Role of patient and hospital characteristics |
| Q56979024 | Salvage Surgery for Squamous Cell Carcinoma of the Head and Neck in the Era of Immunotherapy: Is It Time to Clarify Our Guidelines? |
| Q53968548 | Should all mucosal head and neck cancer patients be treated in high volume centres, or can some be appropriately triaged to local centres for treatment. |
| Q64094411 | Single community-based institutional series of stereotactic body radiation therapy (SBRT) for treatment of liver metastases |
| Q90442589 | Surgery as an alternative to radiotherapy in early-stage nasopharyngeal carcinoma: innovation at the expense of uncertainty |
| Q35858280 | Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States. |
| Q33711438 | Survival Rates Using Individualized Bioselection Treatment Methods in Patients With Advanced Laryngeal Cancer |
| Q88022271 | Testing the Timing: Time Factor in Radiation Treatment for Head and Neck Cancers |
| Q38798385 | The "rocky treatment course": identifying a high-risk subgroup of head and neck cancer patients for supportive interventions |
| Q50100513 | The Case Volume Issue in Head and Neck Oncology |
| Q49348822 | The Effect of Hospital Case Volume on Clinical Outcomes in Patients with Nasopharyngeal Carcinoma: A Multi-institutional Retrospective Analysis (KROG-1106). |
| Q91067850 | The association between facility case volume and overall survival in patients with metastatic renal cell carcinoma in the targeted therapy era |
| Q91050363 | The role of dose escalation and proton therapy in perioperative or definitive treatment of chondrosarcoma and chordoma: An analysis of the National Cancer Data Base |
| Q40421093 | The toxicity and efficacy of concomitant chemoradiotherapy in patients aged 70 years and older with oropharyngeal carcinoma in the intensity-modulated radiotherapy era. |
| Q92055991 | Time abides long enough for those who make use of it |
| Q89622489 | Treating Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck Unsuitable to Receive Cisplatin-Based Therapy |
| Q38713948 | Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer |
| Q35782292 | Treatment of T3 laryngeal cancer in the Netherlands: a national survey |
| Q31160473 | Treatment trends for patients with brain metastases: Does practice reflect the data? |
| Q64247074 | Use of Crowd Innovation to Develop an Artificial Intelligence-Based Solution for Radiation Therapy Targeting |